DARANIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Daranide, and when can generic versions of Daranide launch?
Daranide is a drug marketed by Xeris and is included in one NDA.
The generic ingredient in DARANIDE is dichlorphenamide. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the dichlorphenamide profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DARANIDE?
- What are the global sales for DARANIDE?
- What is Average Wholesale Price for DARANIDE?
Summary for DARANIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Clinical Trials: | 1 |
| Patent Applications: | 3,706 |
| DailyMed Link: | DARANIDE at DailyMed |
Recent Clinical Trials for DARANIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Neurological Disorders and Stroke (NINDS) | Phase 3 |
| University of Rochester | Phase 3 |
Pharmacology for DARANIDE
| Drug Class | Carbonic Anhydrase Inhibitor |
| Mechanism of Action | Carbonic Anhydrase Inhibitors |
US Patents and Regulatory Information for DARANIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xeris | DARANIDE | dichlorphenamide | TABLET;ORAL | 011366-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
